Company to Host Conference Call on Thursday, August 7, 2025 , at 2:30 p.m. PT / 5:30 p.m. ET

Reports total revenue of $654.8 million and adjusted EBITDA of $48.1 million , both at the higher end of guidance

Continues to manage medical cost trends effectively, with trend within expectations across all lines of business

Reiterates full-year 2025 guidance which is inclusive of the now-closed Prospect Health acquisition

ALHAMBRA, Calif. , Aug. 7, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financ

See Full Page